Sentences with phrase «infarction patients»

Conjoint couples» group sessions for postmyocardial infarction patients and spouses: Dissertation Abstracts International.

The patients were enrolled in a major study known as TRIUMPH (Translational Research Investigating Underlying disparities in acute Myocardial infarction Patients» Health) conducted from 2005 to 2008 at 24 U.S. hospitals, including Barnes - Jewish Hospital in St. Louis.

Not exact matches

A 2016 meta - analysis showed that Kona coffee did reduced occurrence of death in patients who have had a myocardial infarction.

In the U.S., one in five Medicare patients is readmitted to a hospital each year at an estimated cost of $ 17.5 billion annually.i To reduce this impact, the Affordable Care Act (ACA) has introduced hospital penalties based on readmissions conditions that commonly affect patients aged 65 and older — including acute myocardial infarction, congestive heart failure and pneumonia.i

Too few patients with retinal infarction, or loss of blood flow in the eye, are evaluated for stroke risk or seen by a neurologist, putting them at increased risk for another stroke, according to preliminary research presented at the American Stroke Association's International Stroke Conference 2018, a world premier meeting dedicated to the science and treatment of cerebrovascular disease for researchers and clinicians.

The study showed that 1 in 100 patients in the study experienced an ischemic stroke within 90 days of a retinal infarction.

The researchers identified 24 745 patients aged 18 years or older who experienced a first myocardial infarction between 1 January 1998 and 25 March 2010 and had no prior history of heart failure.

In patients undergoing transradial primary percutaneous coronary intervention (PCI) for ST elevation myocardial infarction (STEMI), there was no significant difference in the rate of a composite of death, myocardial infarction and stroke whether they were anticoagulated with bivalirudin or unfractioned heparin, according to a study in JACC: Cardiovascular Interventions.

Dr Gho said: «Around one in four patients developed heart failure within four years of a first myocardial infarction in the current era.

Dr. Paul R. Sanberg, Distinguished University Professor, a co-author of the paper, concluded that «these novel data showing BSCB damage in subacute and chronic ischemic stroke may lead to development of new therapeutic approaches for patients with ischemic cerebral infarction.»

Many patients face delayed diagnosis and treatment, meaning the disease progresses and causes further ill health and risk of complications, for example myocardial infarction, blindness, and stroke, which are difficult and expensive to treat.

Data from the BRIGHT trial recently published in the Journal of the American Medical Association demonstrated that bivalirudin was superior to both heparin monotherapy and heparin plus tirofiban for patients with acute myocardial infarction (AMI) undergoing percutaneous coronary intervention (PCI).

The authors measured the proportion of patients in each group who received cardiac catheterization, a coronary revascularization procedure or future noninvasive test, as well as those hospitalized for heart attack (acute myocardial infarction, MI).

High - sensitivity assays for cardiac troponin T can quickly and safely rule out myocardial infarction (MI) in patients presenting to emergency departments (ED) with possible emergency acute coronary syndrome.

The ICD Registry identifies an opportunity for the use of medical therapy for patients with prior myocardial infarction or left ventricular systolic dysfunction; nearly 25 percent of ICD patients did not receive optimal medical therapy with ACE inhibitors and / or beta blockers at discharge.

A phase 2 trial showed a reduction in the combined outcome of death or myocardial infarction (heart attack) in patients treated with otamixaban compared with unfractionated heparin (UFH) plus eptifibatide (an antiplatelet drug) and showed similar bleeding rates with otamixaban at midrange doses.

There have been continued improvements in meeting guideline - recommended Door - to - Balloon (D2B) times of 90 minutes or less for patients with ST - segment elevation myocardial infarction.

This study assessed the association of antidepressant prescription at hospital discharge with the one - year outcomes of patients with acute myocardial infarction (heart attack).

Data from AMIS Plus, the Swiss nationwide registry for acute myocardial infarction, were used to analyse 8,911 heart attack patients admitted to hospitals in Switzerland between March 2005 and August 2016.

The investigators evaluated data from 1,000 patients treated at nine medical centers across the country, including Washington University School of Medicine, that were a part of the Rule Out Myocardial Ischemia / Infarction by Computer Assisted Tomography (ROMICAT - II) clinical trial.

OBTAIN (Outcomes of Beta - Blocker Therapy After Myocardial Infarction) is an observational multicenter registry in which beta - blocker dosing information was collected in patients with an acute heart attack at participating centers to assess the effect of dose on survival.

The primary outcome of death or new myocardial infarction through day 7 occurred in 5.5 percent of the patients treated with otamixaban vs. 5.7 percent of the patients treated with UFH plus eptifibatide.

The authors point to studies of harmful and beneficial effects of thrombolytic and antiarrhythmic drugs for myocardial infarction, for example: «Not only would systematic reviews... have reduced waste resulting from unjustified research, they would also have shown how to reduce morbidity and sometimes mortality, both in patients allocated to relatively less effective or actually harmful treatments in unnecessary trials, and in patients generally,» the authors write.

«In conclusion, the study by Carrero et al in this issue of JAMA provides the best evidence to date that vitamin K antagonists [anticoagulants] are associated with improved clinical outcomes and no significant increased risk of bleeding in patients with myocardial infarction and atrial fibrillation with advanced CKD.»

The patients were followed up through provincial health administrative data (Ontario, Canada) until May 2011 for CV disease (myocardial infarction, stroke, congestive heart failure, revascularization procedures) and death from any cause, analyzed as a composite outcome.

Ischemic mitral regurgitation of moderate severity develops in approximately 10 percent of patients after myocardial infarction.

The new study analyzed heart disease risk factors among more than 3,900 patients who were treated for ST - elevation myocardial infarction, or STEMI — the most severe and deadly type of heart attack — at Cleveland Clinic between 1995 and 2014.

In the randomized study, patients were assigned to receive either intravenous metoprolol or a placebo treatment at the moment of diagnosis of a myocardial infarction during ambulance transit to the catheterization laboratory.

Moreover, all patients recovered within 2 weeks, a far better outcome than for infarction.

Giving intravenous beta blockers before performing a coronary angioplasty in patients who had experienced the deadliest form of heart attack — ST - segment elevation myocardial infarction (STEMI)-- was safe but did not reduce heart attack severity or improve blood flow from the heart's main pumping chamber, according to research presented at the American College of Cardiology's 65th Annual Scientific Session.

A large randomized controlled trial of ischemic postconditioning in patients who had experienced the deadliest form of heart attack — ST - segment elevation myocardial infarction (STEMI)-- failed to show that this procedure significantly reduces death from any cause or hospitalization for heart failure, according to research presented at the American College of Cardiology's 65th Annual Scientific Session.

Delayed or deferred stent implantation in patients experiencing the deadliest form of heart attack — ST - segment elevation myocardial infarction (STEMI)-- failed to reduce death from any cause, hospitalization for heart failure, subsequent heart attacks or the need for a repeat procedure to restore blood flow to the heart, researchers reported at the American College of Cardiology's 65th Annual Scientific Session.

Researchers identified patients from 119 practices who were prescribed aspirin between January 2008 and June 2013, excluding patients receiving aspirin as a secondary prevention due to history of cardiovascular disease such as myocardial infarction, prior stroke, and atrial fibrillation.

The team also investigated the risk of infection while taking into account the duration of current or former statin use, 90 - day cumulative dose, and specific sub-groups of patients who were prescribed statins for different chronic conditions like previous myocardial infarction, peripheral arterial disease, chronic heart failure, chronic kidney disease, and diabetes.

Three of the patients did not complete chemotherapy — one died after consent but prior to chemotherapy; one died during chemotherapy because of an arterial occlusion; and one had a myocardial infarction prior to completion of the four courses of chemotherapy.

Patients received E-CPR for a number of reasons, such as acute myocardial infarction, malignant arrhythmia, myocarditis, acute pulmonary embolism, and hypothermia.

Findings indicate that 306 patients in the arthroplasty group and 286 in the non-surgical group developed myocardial infarction during the follow - up period.

As many as 80 percent of patients with large supratentorial hemispheric infarction strokes die, but research by Mayo Clinic and other medical experts has uncovered ways to significantly reduce deaths in these patients.

J. Marc Simard, professor of neurosurgery at the University of Maryland School of Medicine, along with colleagues at Yale University and Massachusetts General Hospital, found that Cirara, an investigational drug, powerfully reduced brain swelling and death in patients who had suffered a type of large stroke called malignant infarction, which normally carries a high mortality rate.

About 70 patients were eligible based on their diagnosis of a large supratentorial hemispheric infarction stroke, and 40 enrolled in the study.

The researchers analyzed data on more than 69,000 black and white patients with acute myocardial infarction (AMI) treated at 253 hospitals in three states during 2006 - 07.

The management of acute myocardial infarction in the Russian Federation: protocol for a study of patient pathways

Coronary Vasospasm Mimicking ST - Elevation Myocardial Infarction in a Patient With ATRA - Induced Differentiation Syndrome: A case Report and Review of Literature

Research Paper Lipoprotein - Associated Phospholipase A2 Activity Level may be complementary to Cardiactroponin I as a Biomarker for Acute Myocardial Infarction in Chinese Patients with Chest Pain Ting Sun, Qian Zhao, Zhaofang Yin, Zuojun Xu, Yang Zhuo, Li Fan, Zhihua Han, Lei Liu, Changqian Wang J. Biomed 2018; 3: 19 - 25.

The study assessed safety and efficacy of intracoronary autologous transplantation of bone marrow - derived human MSCs in patients with acute myocardial infarction.

Although medical and surgical treatments available today for the ischemic heart disease patients diminish the risk of acute myocardial infarction and reduce to some extent the incidence of recurrent heart attack, one of the unsolved challenges is to affect myocardium remodeling occurring during ischemic heart failure.

Among the 50 trials, 30 were primary prevention trials (general populations, smokers and workers exposed to asbestos, patients with oesophageal dysplasia, male physicians, patients with non-melanoma skin cancer, postmenopausal women, patients undergoing chronic haemodialysis, patients with end stage renal disease, ambulatory elderly women with vitamin D insufficiency, patients with chronic renal failure, older people with femoral neck fractures, patients with diabetes mellitus, elderly women with a low serum 25 - hydroxyvitamin D concentration, health professionals, people with a high fasting plasma total homocysteine concentration, or kidney transplant recipients), and 20 were secondary prevention trials (patients with cardiovascular disease, coronary heart disease, acute myocardial infarction, unstable angina, transient ischaemic attack, stroke, angiographically proved coronary atherosclerosis, vascular disease, or aortic valve stenosis).

We also performed subgroup meta - analyses by type of prevention (primary v secondary: in this study, trials involving healthy populations or patients with any specific disease except for cardiovascular disease were classified as primary prevention trials, and trials involving patients with cardiovascular disease were classified as secondary prevention trials), type of supplement by quality and dose (each supplement, vitamins only, antioxidants only, or antioxidants excluding vitamins), type of outcome (cardiovascular death, angina, fatal or non-fatal myocardial infarction, stroke, or transient ischaemic attack), type of outcome in each supplement, type of study design (randomised, double blind, placebo controlled trial v open label, randomised controlled trial), methodological quality (high v low), duration of treatment (< 5 years v ≥ 5 years), funding source (pharmaceutical industry v independent organisation), provider of supplements (pharmaceutical industry v not pharmaceutical industry), type of control (placebo v no placebo), number of participants (≥ 10000 v < 10000), and supplements given singly or in combination with other vitamin or antioxidant supplements by quality.

[10] Moreover, patients had a significantly elevated relative risk of mortality from myocardial infarction, ranging between 7.3 and 8.1, depending on the length of time since radiation exposure.

Findings: The PROMIS cohort included 9015 patients with acute myocardial infarction and 8629 matched controls.